LRP1B and neoplasm: In agreement with the LRP1B inactivation in many malignancies and the thus postulated putative tumor suppressor function [1–15], we identified NSCLC cell lines with very low (A427, A549) or absent (HCC-44) endogenous LRP1B expression.